h
Let’s Work Together
[email protected]

Meet Arrosa, the perfect theme to elevate your online presentation with.

Via Appia Antica,
224, 00179 Roma, Italy
+1 312 749 8649

Minha conta Área do cliente
Contato BTI Channel BTI Channel BTI Biotechnology Institute BTI Biotechnology Institute
Search here!

Artigos

Frequency of Technical Complications in Fixed Implant Prosthesis: The Effect of Prosthesis Screw Emergence Correction by Computer-Aided Design/Computer-Aided Manufacturing
PMID: 29870304

J Oral Implantol. 2018 Dec;44(6):427-431. Computer-aided design/computer-aided manufacturing (CAD-CAM) technology permits the angular correction of screw emergence into the prosthesis; however, there is lack of controlled clinical studies that assess the frequency of technical complications in angled screw channel restorations. This controlled clinical study was designed to assess technical incidences in angled screw channel restorations. Patients who underwent placement of implant prosthesis between November 2014 and December 2015 were screened.

Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma
  • Autor:
  • Eduardo Anitua
  • Gorka Orive
  • Sánchez-Avila RM
  • Merayo-Lloves J
  • Fernández ML
  • Rodríguez-Gutiérrez LA
  • Rodríguez-Calvo PP
  • Fernández-Vega Cueto A
  • Muruzabal F
PMID: 29760570

Int Med Case Rep J. 2018 May 1;11:97-103. To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) eye drops in patients with glaucoma with secondary ocular surface disorders (OSDs) due to surgeries and topical hypotensive drugs use.

Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders
PMID: 29702971

Medicine (Baltimore). 2018 Apr;97(17):e0242. To evaluate the safety and efficacy of the surgical use of plasma rich in growth factors fibrin membrane (mPRGF) in different ocular surface pathologies.Fifteen patients with different corneal and conjunctival diseases were included in the study. Patients were grouped according to the use of mPRGF as graft (corneal and/or conjunctival) or dressing; they were also grouped according to the surgical subgroup of intervention (persistent corneal ulcer [PCU], keratoplasty, superficial keratectomy, corneal perforation, and pterygium).

Prognosis of Dental Implants Immediately Placed in Sockets Affected by Peri-implantitis: A Retrospective Pilot Study
PMID: 28817136

Int J Periodontics Restorative Dent. 2017 Sep/Oct;37(5):713-719. The aim of this study was to describe a protocol and analyze the outcomes of immediate replacement of failed implants due to peri-implantitis. A total of 17 patients (mean age: 58 ± 10 years) had 22 failed implants that were immediately replaced.

Minimizing the mandibular advancement in an oral appliance for the treatment of obstructive sleep apnea
  • Autor:
  • Eduardo Anitua
  • Joaquín Durán-Cantolla
  • Mohammad H. Alkhraisat
  • Gabriela Zamora
PMID: 28228337

Sleep Med. 2017 Jun:34:226-231. In the treatment of obstructive sleep apnea (OSA) with an oral appliance (OA), there is no gold standard method to fine-tune the mandibular advancement. This study aimed to analyze the effect of gradual increment of mandibular advancement on the evolution of the apnea-hypopnea index (AHI).

Transcrestal Sinus Floor Augmentation by Sequential Drilling and the Use of Plasma Rich in Growth Factors
PMID: 27598424

Int J Oral Maxillofac Implants. 2017 May/June;32(3):e167–e173. There is a paucity of studies that evaluate the treatment outcomes of transcrestal sinus elevation performed without using osteotomes. This study aims to evaluate the 4-year survival of short dental implants placed following transcrestal sinus elevation performed with a frontal cutting drill and to measure the marginal bone stability.

Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology
PMID: 28115245

Ocul Surf. 2017 Apr;15(2):248-256. Develop an autologous culture method for ex vivo expansion of human limbal epithelial progenitor cells (LEPCs) using Plasma Rich in Growth Factors (PRGF) as a growth supplement and as a scaffold for the culture of LEPCs.